| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6065096 | Journal of Allergy and Clinical Immunology | 2014 | 6 Pages |
Abstract
The results of this trial demonstrate that emollient therapy from birth represents a feasible, safe, and effective approach for atopic dermatitis prevention. If confirmed in larger trials, emollient therapy from birth would be a simple and low-cost intervention that could reduce the global burden of allergic diseases.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Eric L. MD, MCR, Joanne R. PhD, Jon M. MD, Kim S. PhD, Michael J. PhD, FRCP, W.H. Irwin FRSE, FMedSci, Sara J. MRCP, MD, Zunqiu MS, Yiyi PhD, Hywel C. DSc, FMedSci,